目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 48)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 INCLUSIONS AND EXCLUSIONS
1.3.4 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 53)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 VENDOR REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 END-USER ASSESSMENT-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 RESEARCH ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 63)
FIGURE 7 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 8 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PLATFORM, 2022 VS. 2027 (USD MILLION)
FIGURE 9 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET

4 PREMIUM INSIGHTS (Page No. - 67)
4.1 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET OVERVIEW
FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET
4.2 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GLUCOSE MONITORING PRODUCTS SEGMENT WILL DOMINATE MARKET IN 2027
4.3 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET SHARE, BY MODE OF PURCHASE (2022)
FIGURE 14 OTC TESTING PRODUCTS SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2022
4.4 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET SHARE, BY PLATFORM, 2022 VS. 2027
FIGURE 15 LATERAL FLOW ASSAYS WILL CONTINUE TO DOMINATE MARKET IN 2027
4.5 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 71)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 High prevalence of infectious diseases
FIGURE 18 HIV INFECTION, BY REGION, 2021
5.2.1.2 Increasing incidence of target conditions
5.2.1.3 Supportive government policies
5.2.1.4 Dearth of skilled laboratory technicians
5.2.1.5 Rising number of CLIA-waived POC tests
TABLE 1 RECENT WAIVERS FOR PRODUCTS
5.2.2 RESTRAINTS
5.2.2.1 Pricing pressure owing to reimbursement cuts and budget constraints
5.2.2.2 Stringent regulatory policies
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Healthcare decentralization
5.2.3.3 Increasing provider awareness about novel technologies
5.2.3.4 POC tests with multiplexing capabilities
5.2.3.5 Growing investments and funding for product development
5.2.4 CHALLENGES
5.2.4.1 Lack of alignment with definitive central lab methods
5.2.4.2 Inadequate adoption of POC devices in professional settings
5.2.4.3 Reluctance to change existing diagnostic practices
5.2.4.4 Premium pricing of novel platforms
5.3 TECHNOLOGY ANALYSIS: EMERGING POINT-OF-CARE APPLICATIONS
5.3.1 SEPSIS BIOMARKERS
5.3.2 STROKE/CARDIAC MARKERS
5.3.3 THYROID TESTING
5.3.4 DNA TESTING
5.3.5 ENDOCRINE TESTING
5.3.6 RESPIRATORY DIAGNOSTICS
5.4 REGULATORY LANDSCAPE
TABLE 2 KEY REGULATORY BODIES AND GOVERNMENT AGENCIES
5.4.1 KEY REGULATORY GUIDELINES
5.4.1.1 US
FIGURE 19 US: REGULATORY PROCESS FOR IVD DEVICES
5.4.1.2 Canada
FIGURE 20 CANADA: REGULATORY PROCESS FOR IVD DEVICES
5.4.1.3 Europe
FIGURE 21 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
5.4.1.4 Japan
FIGURE 22 JAPAN: REGULATORY PROCESS FOR IVD DEVICES
5.4.1.5 China
TABLE 3 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.6 India
FIGURE 23 INDIA: REGULATORY PROCESS FOR IVD DEVICES
5.4.1.7 Brazil
FIGURE 24 BRAZIL: REGULATORY PROCESS FOR IVD DEVICES
5.5 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING REGULATION AND DISTRIBUTION STAGES
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
FIGURE 26 SUPPLY CHAIN ANALYSIS
5.7 PRICING TREND ANALYSIS
TABLE 4 AVERAGE PRICE OF GLUCOSE MONITORING AND CARDIOMETABOLIC MONITORING PRODUCTS, BY COUNTRY, 2021 (USD)
TABLE 5 AVERAGE PRICE OF INFECTIOUS DISEASE TESTING PRODUCTS, BY COUNTRY, 2021 (USD)
TABLE 6 AVERAGE PRICE OF OTHER POINT-OF-CARE TESTING PRODUCTS, BY COUNTRY, 2021 (USD)
5.8 PORTER’S FIVE FORCES
5.8.1 OVERVIEW
TABLE 7 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.2 BARGAINING POWER OF BUYERS
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 THREAT OF NEW ENTRANTS
5.8.5 THREAT OF SUBSTITUTES
5.8.6 INTENSITY OF COMPETITIVE RIVALRY
5.9 PATENT ANALYSIS
FIGURE 27 TOP 10 PATENT APPLICANTS FOR CARDIAC MARKER TESTING (JANUARY 2012-NOVEMBER 2022)
FIGURE 28 TOP 10 PATENT OWNERS FOR POINT-OF-CARE DIAGNOSTICS (JANUARY 2012-NOVEMBER 2022)
FIGURE 29 ECOSYSTEM COVERAGE: PARENT MARKET (IN VITRO DIAGNOSTICS)
5.10 KEY CONFERENCES AND EVENTS
TABLE 8 POINT-OF-CARE & RAPID DIAGNOSTICS MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS, 2021-2023
5.11 CASE STUDY
5.11.1 DEVELOPMENT OF HIGH-SENSITIVITY TROPONIN I
TABLE 9 CASE 1: DIAGNOSING LOWER LEVELS OF TROPONIN IN CARDIAC PATIENTS
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR CARDIAC MARKER TESTING KITS AND INSTRUMENTS
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRODUCT SEGMENTS (%)
5.13 KEY BUYING CRITERIA
TABLE 11 KEY BUYING CRITERIA FOR PRODUCTS

6 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT (Page No. - 98)
6.1 INTRODUCTION
TABLE 12 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
6.2 GLUCOSE MONITORING PRODUCTS
TABLE 13 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 14 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 15 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 16 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 17 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 18 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.2.1 STRIPS
6.2.1.1 Strips make blood glucose testing easy and hassle-free
TABLE 19 GLUCOSE MONITORING STRIPS MARKET, BY REGION, 2020-2027 (USD MILLION)
6.2.2 METERS
6.2.2.1 Extremely helpful in monitoring blood glucose levels and adjusting therapeutic regimens
TABLE 20 GLUCOSE MONITORING METERS MARKET, BY REGION, 2020-2027 (USD MILLION)
6.2.3 LANCETS AND LANCING DEVICES
6.2.3.1 Lancets and lancing devices segment to register lower growth in glucose monitoring products market
TABLE 21 GLUCOSE MONITORING LANCETS AND LANCING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
6.3 COVID-19 TESTING PRODUCTS
6.3.1 COVID-19 PANDEMIC ACCELERATED DEMAND FOR POC/RAPID DIAGNOSTIC PRODUCTS
TABLE 22 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COVID-19 TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 23 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COVID-19 TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 24 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COVID-19 TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 25 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COVID-19 TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 26 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COVID-19 TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.4 CARDIOMETABOLIC MONITORING PRODUCTS
TABLE 27 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 28 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 29 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 30 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 31 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 32 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.4.1 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
6.4.1.1 Technological advancements in blood gas/electrolyte products to drive market
TABLE 33 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR BLOOD GAS/ELECTROLYTE TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.4.2 CARDIAC MARKER TESTING PRODUCTS
6.4.2.1 Rising prevalence of heart diseases and development of new POC test to support market growth
TABLE 34 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIAC MARKER TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.4.3 HBA1C TESTING PRODUCTS
6.4.3.1 Government initiatives promoting regular use of HbA1c testing
TABLE 35 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HBA1C TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5 INFECTIOUS DISEASE TESTING PRODUCTS
TABLE 36 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 37 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 38 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 39 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 40 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 41 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.1 HIV TESTING PRODUCTS
6.5.1.1 Rising prevalence of HIV to drive market
TABLE 42 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HIV TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 43 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HIV TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 44 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HIV TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 45 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HIV TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.2 RESPIRATORY INFECTION TESTING PRODUCTS
6.5.2.1 POCT products for diagnosis of respiratory infections offer lower sensitivity
TABLE 46 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR RESPIRATORY INFECTION TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 47 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR RESPIRATORY INFECTION TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 48 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR RESPIRATORY TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 49 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR RESPIRATORY INFECTION TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.3 HEPATITIS C TESTING PRODUCTS
6.5.3.1 Central and East Asia among highly affected regions by hepatitis C
TABLE 50 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEPATITIS C TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 51 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEPATITIS C TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 52 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEPATITIS C TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 53 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEPATITIS C TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.4 HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS
6.5.4.1 Rising prevalence of HAIs to drive market
TABLE 54 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 55 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 56 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 57 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.5 INFLUENZA TESTING PRODUCTS
6.5.5.1 Rising influenza prevalence to drive demand for influenza testing products
TABLE 58 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFLUENZA TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 59 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFLUENZA TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 60 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFLUENZA TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 61 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFLUENZA TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.6 TROPICAL DISEASE TESTING PRODUCTS
6.5.6.1 Increasing government funding for use of POC in tropical disease testing to support market growth
TABLE 62 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TROPICAL DISEASE TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 63 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TROPICAL DISEASE TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 64 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TROPICAL DISEASES PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 65 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TROPICAL DISEASE TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.7 SEXUALLY TRANSMITTED DISEASE TESTING PRODUCTS
TABLE 66 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR STD TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 67 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR STD TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 68 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR STD TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 69 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR STD TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 70 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR STD TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.7.1 Syphilis testing products
6.5.7.1.1 Introduction of rapid tests for syphilis to support market growth
TABLE 71 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR SYPHILIS TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.7.2 Human papillomavirus (HPV) testing products
6.5.7.2.1 Technological advancements to aid market growth
TABLE 72 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HPV TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.7.3 Chlamydia trachomatis testing products
6.5.7.3.1 Growing incidence of chlamydia and rising awareness among patients to drive market
TABLE 73 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CHLAMYDIA TRACHOMATIS TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.7.4 Herpes simplex virus (HSV) testing products
6.5.7.4.1 Increasing incidence of HSV to boost adoption of rapid tests
TABLE 74 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HSV TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.8 TUBERCULOSIS (TB) TESTING PRODUCTS
6.5.8.1 Rising prevalence of TB and initiatives by governments to propel demand for rapid TB tests
TABLE 75 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TB TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 76 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TB TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 77 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TB TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 78 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TB TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.9 CLOSTRIDIUM DIFFICILE INFECTION (CDI) TESTING PRODUCTS
6.5.9.1 Increasing cases of CDI infections among hospitalized patients to support market growth
TABLE 79 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CDI TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 80 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CDI TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 81 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CDI TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 82 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CDI TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.5.10 OTHER INFECTIOUS DISEASE TESTING PRODUCTS
TABLE 83 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASE TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 84 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASE TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 85 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASE TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 86 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASE TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.6 COAGULATION MONITORING PRODUCTS
TABLE 87 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 88 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 89 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 90 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 91 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 92 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.6.1 PT/INR TESTING PRODUCTS
6.6.1.1 Most commonly used coagulation monitoring method
TABLE 93 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PT/INR TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.6.2 ACT/APTT TESTING PRODUCTS
6.6.2.1 Rising number of patients undergoing angioplasty and dialysis globally to support market growth
TABLE 94 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR ACT/APTT TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.7 PREGNANCY AND FERTILITY TESTING PRODUCTS
TABLE 95 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 96 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 97 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 98 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 99 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 100 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.7.1 PREGNANCY TESTING PRODUCTS
6.7.1.1 Rising inclination toward home testing to support market growth
TABLE 101 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.7.2 FERTILITY TESTING PRODUCTS
6.7.2.1 Increasing awareness of fertility testing to drive market
TABLE 102 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR FERTILITY TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.8 TUMOR/CANCER MARKER TESTING PRODUCTS
6.8.1 INCREASING PREVALENCE OF CANCER TO BOOST DEMAND FOR RAPID TESTING
TABLE 103 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 104 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 105 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 106 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 107 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.9 URINALYSIS TESTING PRODUCTS
6.9.1 RISING PREVALENCE OF URINARY TRACT INFECTIONS TO DRIVE MARKET
TABLE 108 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 109 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 110 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 111 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 112 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.10 CHOLESTEROL TESTING PRODUCTS
6.10.1 RISING OBESITY LEVELS TO DRIVE ADOPTION OF CHOLESTEROL TESTING PRODUCTS
TABLE 113 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 114 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 115 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 116 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 117 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.11 HEMATOLOGY TESTING PRODUCTS
6.11.1 PREFERENCE FOR LABORATORY-BASED TESTS AMONG USERS TO IMPEDE MARKET GROWTH
TABLE 118 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 119 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 120 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 121 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 122 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.12 DRUGS-OF-ABUSE TESTING PRODUCTS
6.12.1 RISING CONSUMPTION OF ILLICIT DRUGS TO BOOST DEMAND FOR TESTING
TABLE 123 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 124 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 125 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 126 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 127 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.13 FECAL OCCULT TESTING PRODUCTS
6.13.1 LACK OF PROPER TRAINING FOR FECAL OCCULT TESTING TO HAMPER MARKET GROWTH
TABLE 128 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 129 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 130 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 131 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 132 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.14 THYROID-STIMULATING HORMONE (TSH) TESTING PRODUCTS
6.14.1 RISING CASES OF THYROID TO BOOST ADOPTION OF RAPID TESTS
TABLE 133 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TSH TESTING PRODUCTS, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 134 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TSH TESTING PRODUCTS, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 135 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TSH TESTING PRODUCTS, BY END USER, 2020-2027 (USD MILLION)
TABLE 136 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TSH TESTING PRODUCTS, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 137 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR TSH TESTING PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
6.15 OTHER PRODUCTS
TABLE 138 OTHER POINT-OF-CARE AND RAPID DIAGNOSTIC PRODUCTS MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 139 OTHER POINT-OF-CARE AND RAPID DIAGNOSTIC PRODUCTS MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 140 OTHER POINT-OF-CARE AND RAPID DIAGNOSTIC PRODUCTS MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 141 OTHER POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY SAMPLE, 2020-2027 (USD MILLION)
TABLE 142 OTHER POINT-OF-CARE AND RAPID DIAGNOSTIC PRODUCTS MARKET, BY REGION, 2020-2027 (USD MILLION)

7 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PLATFORM (Page No. - 177)
7.1 INTRODUCTION
TABLE 143 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
7.2 LATERAL FLOW ASSAYS
7.2.1 INCREASING ADOPTION OF LFA TESTING PRODUCTS IN HOME CARE SETTINGS TO DRIVE MARKET
TABLE 144 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2020-2027 (USD MILLION)
7.3 IMMUNOASSAYS
7.3.1 RISING INCIDENCE OF CANCER AND GROWING AWARENESS ABOUT IMMUNOASSAY PLATFORMS TO SUPPORT MARKET GROWTH
TABLE 145 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR IMMUNOASSAYS, BY REGION, 2020-2027 (USD MILLION)
7.4 MICROFLUIDICS
7.4.1 EMERGING PLATFORM IN POC DIAGNOSTICS MARKET
TABLE 146 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR MICROFLUIDICS, BY REGION, 2020-2027 (USD MILLION)
7.5 DIPSTICKS
7.5.1 DIPSTICKS HELP IN ROUTINE ANALYSIS OF SEVERAL MEDICAL CONDITIONS
TABLE 147 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR DIPSTICKS, BY REGION, 2020-2027 (USD MILLION)
7.6 MOLECULAR DIAGNOSTICS
TABLE 148 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 149 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
7.6.1 RT-PCR
7.6.1.1 COVID-19 testing boosted demand for RT-PCR technology
TABLE 150 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR RT-PCR, BY REGION, 2020-2027 (USD MILLION)
7.6.2 INAAT
7.6.2.1 Cost benefits of INAAT to drive adoption
TABLE 151 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INAAT, BY REGION, 2020-2027 (USD MILLION)
7.6.3 OTHER TECHNOLOGIES
TABLE 152 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2020-2027 (USD MILLION)

8 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY MODE OF PURCHASE (Page No. - 187)
8.1 INTRODUCTION
TABLE 153 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
8.2 OTC TESTING PRODUCTS
8.2.1 RISING FOCUS ON HOME CARE TO BOOST DEMAND FOR OTC TESTING PRODUCTS
TABLE 154 OTC POINT-OF-CARE AND RAPID TESTING PRODUCTS MARKET, BY REGION, 2020-2027 (USD MILLION)
8.3 PRESCRIPTION-BASED TESTING PRODUCTS
8.3.1 GROWING PREVALENCE OF LIFESTYLE DISEASES AND FAVORABLE REIMBURSEMENT TO DRIVE MARKET
TABLE 155 PRESCRIPTION-BASED POINT-OF-CARE AND RAPID TESTING PRODUCTS MARKET, BY REGION, 2020-2027 (USD MILLION)

9 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY SAMPLE (Page No. - 191)
9.1 INTRODUCTION
TABLE 156 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY SAMPLE, 2020-2027 (USD MILLION)
9.2 BLOOD
9.2.1 RISING APPLICATION OF BLOOD SAMPLES IN DETECTION OF VARIOUS DISEASES TO DRIVE GROWTH
TABLE 157 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR BLOOD SAMPLES, BY REGION, 2020-2027 (USD MILLION)
9.3 URINE
9.3.1 GROWING PREVALENCE OF KIDNEY DISORDERS TO BOOST MARKET GROWTH
TABLE 158 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR URINE SAMPLES, BY REGION, 2020-2027 (USD MILLION)
9.4 NASAL AND OROPHARYNGEAL SWABS
9.4.1 INCREASING PREVALENCE OF RESPIRATORY INFECTIONS TO PROPEL MARKET GROWTH
TABLE 159 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR NASAL AND OROPHARYNGEAL SWABS, BY REGION, 2020-2027 (USD MILLION)
9.5 OTHER SAMPLES
TABLE 160 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR OTHER SAMPLES, BY REGION, 2020-2027 (USD MILLION)

10 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY END USER (Page No. - 196)
10.1 INTRODUCTION
TABLE 161 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
10.2 CLINICAL LABORATORIES
10.2.1 IMPROVEMENTS IN CLINICAL DIAGNOSTICS AND TESTING TECHNOLOGIES TO DRIVE MARKET
TABLE 162 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020-2027 (USD MILLION)
10.3 AMBULATORY CARE FACILITIES AND PHYSICIANS’ OFFICES
10.3.1 RAPID RESULT GENERATION AND AVAILABILITY OF IMMEDIATE PATIENT CARE—MAJOR FACTORS DRIVING MARKET GROWTH
TABLE 163 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR AMBULATORY CARE FACILITIES AND PHYSICIANS’ OFFICES, BY REGION, 2020-2027 (USD MILLION)
10.4 PHARMACIES, RETAIL CLINICS, AND E-COMMERCE PLATFORMS
10.4.1 CONVENIENCE AND EASE OF EXPERT ACCESS TO DRIVE MARKET
TABLE 164 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PHARMACIES, RETAIL CLINICS, AND E-COMMERCE PLATFORMS, BY REGION, 2020-2027 (USD MILLION)
10.5 HOSPITALS, CRITICAL CARE CENTERS, AND URGENT CARE CENTERS
10.5.1 HOSPITALS LARGEST END USERS OF POC DIAGNOSTICS
TABLE 165 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HOSPITALS, CRITICAL CARE CENTERS, AND URGENT CARE CENTERS, BY REGION, 2020-2027 (USD MILLION)
10.6 HOME CARE AND SELF-TESTING
10.6.1 INCREASING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET
TABLE 166 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR HOME CARE AND SELF-TESTING, BY REGION, 2020-2027 (USD MILLION)
10.7 OTHER END USERS
TABLE 167 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)

11 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY REGION (Page No. - 203)
11.1 INTRODUCTION
TABLE 168 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY REGION, 2020-2027 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 32 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET SNAPSHOT
TABLE 169 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 170 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 171 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 172 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 173 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 174 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 175 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 176 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 177 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 178 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 179 NORTH AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY SAMPLE, 2020-2027 (USD MILLION)
11.2.1 US
11.2.1.1 US dominates North American POC diagnostics market
TABLE 180 US: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 181 US: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 182 US: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 183 US: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 184 US: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Rising government initiatives to support growth of POC diagnostics market in Canada
TABLE 185 CANADA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 186 CANADA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 187 CANADA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 188 CANADA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 189 CANADA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.3 EUROPE
TABLE 190 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 191 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 192 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 193 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 194 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 195 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 196 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 197 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 198 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 199 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 200 EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY SAMPLE, 2020-2027 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Largest market for POC diagnostics in Europe
TABLE 201 GERMANY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 202 GERMANY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 203 GERMANY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 204 GERMANY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 205 GERMANY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 Growing public-private collaborations for product development to drive market
TABLE 206 FRANCE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 207 FRANCE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 208 FRANCE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 209 FRANCE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 210 FRANCE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.3.3 UK
11.3.3.1 Benefits of POC diagnostics to support market growth
TABLE 211 UK: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 212 UK: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 213 UK: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 214 UK: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 215 UK: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Rising prevalence of chronic diseases to drive demand for POC diagnostics
TABLE 216 ITALY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 217 ITALY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 218 ITALY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 219 ITALY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 220 ITALY: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Rising geriatric population to support market growth
TABLE 221 SPAIN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 222 SPAIN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 223 SPAIN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 224 SPAIN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 225 SPAIN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 226 REST OF EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 227 REST OF EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 228 REST OF EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 229 REST OF EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 230 REST OF EUROPE: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET SNAPSHOT
TABLE 231 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 232 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 233 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 234 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 235 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 236 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 237 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 238 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 239 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 240 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 241 ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY SAMPLE, 2020-2027 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Japan to dominate Asia Pacific POC diagnostics market during forecast period
TABLE 242 JAPAN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 243 JAPAN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 244 JAPAN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 245 JAPAN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 246 JAPAN: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Rising investments by market players and government to drive market
TABLE 247 CHINA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 248 CHINA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 249 CHINA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 250 CHINA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 251 CHINA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.4.3 INDIA
11.4.3.1 High burden of chronic diseases to support market growth
TABLE 252 INDIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 253 INDIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 254 INDIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 255 INDIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 256 INDIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 Government initiatives to support adoption of point-of-care testing
TABLE 257 AUSTRALIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 258 AUSTRALIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 259 AUSTRALIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 260 AUSTRALIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 261 AUSTRALIA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 Increased funding and product development to propel market growth
TABLE 262 SOUTH KOREA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 263 SOUTH KOREA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 264 SOUTH KOREA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 265 SOUTH KOREA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 266 SOUTH KOREA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.4.6 REST OF ASIA PACIFIC
TABLE 267 REST OF ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 268 REST OF ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 269 REST OF ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 270 REST OF ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 271 REST OF ASIA PACIFIC: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.5 LATIN AMERICA
TABLE 272 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 273 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 274 LATIN AMERICA: POINT-OF-CARE AND aDIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 275 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 276 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 277 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 278 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 279 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 280 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 281 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 282 LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY SAMPLE, 2020-2027 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 Rising prevalence of diabetes to support market growth
TABLE 283 BRAZIL: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 284 BRAZIL: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 285 BRAZIL: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 286 BRAZIL: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 287 BRAZIL: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 Rising prevalence of diabetes and cancer to drive market
TABLE 288 MEXICO: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 289 MEXICO: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 290 MEXICO: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 291 MEXICO: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 292 MEXICO: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
TABLE 293 REST OF LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 294 REST OF LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 295 REST OF LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 296 REST OF LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 297 REST OF LATIN AMERICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING PREVALENCE OF HIV TO DRIVE MARKET
TABLE 298 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 299 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 300 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 301 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 302 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 303 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY TESTING PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 304 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
TABLE 305 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION)
TABLE 306 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 307 MIDDLE EAST & AFRICA: POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET, BY SAMPLE, 2020-2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 289)
12.1 INTRODUCTION
TABLE 308 OVERVIEW OF STRATEGIES ADOPTED BY COMPANIES (2019−2022)
12.2 REVENUE SHARE ANALYSIS
FIGURE 34 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET
12.3 MARKET SHARE ANALYSIS
FIGURE 35 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
12.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021)
12.4.1 STARS
12.4.2 EMERGING LEADERS
12.4.3 PERVASIVE PLAYERS
12.4.4 PARTICIPANTS
FIGURE 36 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
12.5 COMPETITIVE LEADERSHIP MAPPING: STARTUP/SME EVALUATION QUADRANT (2021)
12.5.1 PROGRESSIVE COMPANIES
12.5.2 RESPONSIVE COMPANIES
12.5.3 DYNAMIC COMPANIES
12.5.4 STARTING BLOCKS
FIGURE 37 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/STARTUPS) (2021)
12.6 COMPETITIVE BENCHMARKING
12.6.1 FOOTPRINT ANALYSIS OF COMPANIES
TABLE 309 OVERALL FOOTPRINT OF COMPANIES
TABLE 310 PRODUCT FOOTPRINT OF COMPANIES
TABLE 311 REGIONAL FOOTPRINT OF COMPANIES
12.7 COMPETITIVE SCENARIO
12.7.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 312 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: KEY PRODUCT LAUNCHES AND APPROVALS (JANUARY 2019-OCTOBER 2022)
12.7.2 DEALS
TABLE 313 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: KEY DEALS (JANUARY 2019-OCTOBER 2022)
12.7.3 OTHER DEVELOPMENTS
TABLE 314 POINT-OF-CARE AND RAPID DIAGNOSTICS MARKET: OTHER KEY DEVELOPMENTS (JANUARY 2019-OCTOBER 2022)

13 COMPANY PROFILES (Page No. - 304)
13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View)*
13.1.1 ABBOTT LABORATORIES
TABLE 315 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
13.1.2 SIEMENS HEALTHINEERS AG
TABLE 316 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
FIGURE 39 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021)
13.1.3 F. HOFFMANN-LA ROCHE LTD.
TABLE 317 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021)
13.1.4 QUIDEL CORPORATION
TABLE 318 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 41 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
13.1.5 DANAHER CORPORATION
TABLE 319 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
13.1.6 BECTON, DICKINSON AND COMPANY
TABLE 320 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
13.1.7 THERMO FISHER SCIENTIFIC
TABLE 321 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 44 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
13.1.8 BIOMÉRIEUX S.A.
TABLE 322 BIOMÉRIEUX S.A.: BUSINESS OVERVIEW
FIGURE 45 BIOMÉRIEUX S.A.: COMPANY SNAPSHOT (2021)
13.1.9 CHEMBIO DIAGNOSTICS, INC.
TABLE 323 CHEMBIO DIAGNOSTICS, INC.: BUSINESS OVERVIEW
FIGURE 46 CHEMBIO DIAGNOSTICS, INC.: COMPANY SNAPSHOT (2021)
13.1.10 EKF DIAGNOSTICS
TABLE 324 EKF DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 47 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2021)
13.1.11 TRINITY BIOTECH PLC
TABLE 325 TRINITY BIOTECH PLC: BUSINESS OVERVIEW
FIGURE 48 TRINITY BIOTECH PLC: COMPANY SNAPSHOT (2021)
13.1.12 INSTRUMENTATION LABORATORY (A WERFEN COMPANY)
TABLE 326 INSTRUMENTATION LABORATORY: BUSINESS OVERVIEW
13.1.13 NOVA BIOMEDICAL
TABLE 327 NOVA BIOMEDICAL: BUSINESS OVERVIEW
13.1.14 PTS DIAGNOSTICS
TABLE 328 PTS DIAGNOSTICS: BUSINESS OVERVIEW
13.1.15 SEKISUI DIAGNOSTICS
TABLE 329 SEKISUI DIAGNOSTICS: BUSINESS OVERVIEW
13.1.16 EUROLYSER DIAGNOSTICA GMBH
TABLE 330 EUROLYSER DIAGNOSTICA GMBH: BUSINESS OVERVIEW
13.1.17 RESPONSE BIOMEDICAL
TABLE 331 RESPONSE BIOMEDICAL: BUSINESS OVERVIEW
13.1.18 ALFA SCIENTIFIC DESIGNS, INC.
TABLE 332 ALFA SCIENTIFIC DESIGNS, INC: BUSINESS OVERVIEW
13.1.19 BODITECH MED INC.
TABLE 333 BODITECH MED INC.: BUSINESS OVERVIEW
13.1.20 BTNX INC.
TABLE 334 BTNX INC.: BUSINESS OVERVIEW
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS
13.2.1 LIFESCAN IP HOLDINGS, LLC
13.2.2 ASCENSIA DIABETES CARE
13.2.3 FLUXERGY
13.2.4 PRECISION BIOSENSOR, INC.
13.2.5 ACON LABORATORIES, INC.
13.2.6 A. MENARINI DIAGNOSTICS S.R.L.
13.2.7 ORASURE TECHNOLOGIES, INC.
13.2.8 MANKIND PHARMA
13.2.9 TERUMO CORPORATION
13.2.10 GRIFOLS, S.A.
13.2.11 DIASORIN S.P.A.
13.2.12 ACCUBIOTECH CO., LTD.
13.2.13 MERIDIAN BIOSCIENCE
13.2.14 BIOCARTIS
13.2.15 GENESTAT MOLECULAR DIAGNOSTICS, LLC.

14 APPENDIX (Page No. - 390)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS